Payers to pharma: Here’s what we’re missing in hep C drugs February 17, 2017By Tracey WalkerA Precision for Value survey highlights what can be done in order to encourage payers to ease coverage policies for these drugs in the next wave of HCV treatment. Ten ways the FDA is addressing the opioid epidemic February 11, 2017By Aubrey WestgateScott Winiecki, MD, of the FDA Center for Drug Evaluation and Research, shares how the FDA is working to address the opioid epidemic. Top strategies for incorporating PDMP data into physician work flow February 09, 2017By Aubrey WestgateHow can physicians, already struggling to keep up with mounting regulations and larger patient loads, use PDMPs in more effective and efficient ways? New diabetes medications help address linked diseasesExperts share updates on new diabetes medications, and provide an overview of what’s coming. Poll: Few consumers trust health orgs, pharma January 31, 2017By Karen AppoldA new report has troubling findings for payers, providers, and technology companies. Here are the key takeaways, and reactions from experts. Top 3 pharmacy challenges in 2017: Two-pronged solutionHere are three pharmacy challenges facing healthcare executives and a two-pronged solution to help solve them. Top challenges in cancer care January 14, 2017By Tracey WalkerCancer drug costs remain the most critical challenge in care, among other things. Watch list 2017: Top therapeutic areas January 03, 2017By Mari EdlinFind out about the latest treatment and drug pipeline developments Top pharmacy challenges of 2017 December 28, 2016By Mari EdlinHigh drug prices continue to plague payers, but various contributing factors intensify the problem. Will new autoimmune drugs address cost concerns? December 27, 2016By Erin Bastick PharmDFind out what’s in the drug pipeline for autoimmune disease.